PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3000 participants.
Also called NCT04149535
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 3,000 participants
- Sponsor
- Registry
-
NCT04149535
-
- Other papers using this trial's data
- Cerebral Embolic Protection by Geographic Region: A Post Hoc Analysis of the PROTECTED TAVR Randomized Clinical Trial
- Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Denmark, France, Germany, Italy
- Registry status
- Completed
Technical summary
Registry record NCT04149535. Randomized; no masking; primary purpose treatment. Start 2020-02-07 (actual); primary completion 2022-02-01 (actual). Results posted on 2023-02-02.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement
- Acronym
- PROTECTED TAVR
- Condition
- Stroke
- Intervention (Device)
- Sentinel® Cerebral Protection System
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct04149535- Content hash
a2e66a000d6e498d58e673eecd646d099dbe4b2652af9410f826aeaa6eb2efbf